CLDN3 and colon carcinoma: The results showed that the CPE is a gene transfer system and can be considered as an appealing therapeutic agent in colon carcinomas through the targeting of claudin-3 and/or claudin-4 which lead to rapid and impressive tumor cell killing in both in vitro and in vivo conditions [46].